After an injury, your own cells perform the repair. A regenerative practice adds two things. It improves the biological environment the repair happens in. And it delivers a precise cellular catalyst to the injured spot under imaging guidance. If the metabolic terrain stays inflamed, even a well-aimed biologic treatment fails.
A patient arrives with a folder. It holds scans from the emergency room, a discharge note that says nothing is broken, and six weeks of physical therapy notes. It also holds a question nobody has answered: if nothing is wrong, why is this the same as it was in March?
The honest answer starts with a line that sounds like a limit. It is actually the whole method.
What does a regenerative practice add to injury recovery?
Your cells do the repair, from your raw material, on your metabolic budget. When conditions allow, it is a powerful process. Nothing in a syringe replaces it. A physician adds two things, and it pays to be precise about both. The gap between them is where most of the letdown in this field comes from.
- Optimize the biological environment where the repair has to happen. That means whole-body inflammation, blood sugar control, vitamins and minerals, sleep, nicotine exposure, and the load the tissue is getting.
- Deliver a precise cellular catalyst to the structure that needs it. It is tested, placed under imaging guidance, and timed for a point in healing when a catalyst has something to work on.
We are the catalyst and the conditions. That is the whole offer. It is smaller than the promises made elsewhere in regenerative medicine, and it is the version that holds up against results.
It also carries a rule that has to be said before anyone spends money. If the metabolic terrain remains inflamed, even a rigorous, correctly targeted, guideline-compliant biologic intervention will fail. It will fail quietly. The procedure was done right, and the note reads well. The patient decides the treatment does not work. What really happened is that a repair signal went into a system that could not carry it out.
Why does metabolic health matter after an injury?
There is a fair objection. Terrain is a chronic-disease argument, and an injury is an event. Somebody hit your car. You fell off a ladder. What does insulin resistance have to do with a torn ligament?
Three things, and they compound.
The repair demand is sudden and large
Wear and tear builds up over years, and the body meets it with a slow, low-level repair effort. An injury demands a burst of work over weeks: new collagen, new blood vessels, rebuilding. A system with little reserve can handle the slow demand and fail the sudden one. That is why people are shocked by how badly they recover from something they would have shrugged off ten years earlier.
The injury adds inflammation to whatever was already there
In a healthy body, local inflammation after an injury is needed, and it ends on its own. Stack it on top of chronic whole-body inflammation, and the two do not simply sit side by side. The baseline raises the bar the short-term response has to work against. The shut-off phase, the part meant to switch the process off, is where it usually fails. The biochemistry is set out in Joint Pain and Systemic Inflammation.
The window is short and it does not reopen
Chronic wear gives you years to step in. An injury gives you a set arc: inflammation, then rebuilding, then remodeling. What is not fixed during that arc cannot be fixed later at the same cost. So the first twelve weeks are worth more than any other twelve weeks in the whole course. What happens in them has its own article.
The evidence for this is real and it is also honest about its limits
Two findings belong together. Using only the first would be advocacy.
Researchers pooled and graded the risk factors for rotator cuff tendinopathy. What came out was not a list of mechanical strains. It was a metabolic, whole-body profile. That is the pattern across bone, joint, muscle and tendon medicine. The tissue that fails is usually failing in a body that made failure more likely.
Then there is the result that cuts the other way. One randomized trial was reanalyzed against body mass index. The link held for microfragmented adipose tissue and vanished for platelet-rich plasma. Same patients, same measure, two products, opposite answers. That complicates the simple version of our own argument, and we publish it for exactly that reason. Terrain is not a general moral about health. It acts through specific mechanisms on specific products in specific tissues. The right response is to measure, not assume. What gets measured is in The Metabolic Audit.
A confession, because it belongs here
For years, the standard excuse for a poor result after an injection was patient factors. It was vague and usually meant as blame. The patient did not do the rehab. The patient is out of shape. That framing is unkind and lazy, and it produced nothing you could act on.
The useful version is this: most of what got called a patient factor is a biological state you can measure and change. Hemoglobin A1c is a number. So are hsCRP, 25-hydroxyvitamin D, fasting insulin, and hours of sleep. Once they are numbers, they stop being character judgments and start being a plan. hsCRP and inflammation biomarkers covers this in detail.
What the published guidance implies without ever saying it
Read the sequencing language in the guideline documents and the same structure shows up. The 2025 ASIPP document places regenerative therapy only after a diagnostic work-up, and alongside exercise, physical therapy and lifestyle care. ESSKA-ICRS will not call a case appropriate unless conservative care has been tried. The multispecialty guidelines only ever asked about problems that had already lasted.
In committee language, those documents describe a treatment that is one part of a plan. They leave one rule unstated, and it is the one this practice starts with. A plan has prerequisites, and the prerequisites are biological. A catalyst given before there is anything to work on, or into a body that cannot follow the instruction, is spent, not banked. The timing half of that is worked through in the first twelve weeks.
What does “nothing is broken” on a discharge summary really mean?
A discharge note saying nothing is broken has answered one question: nothing needs an operation tonight. It has not shown what was injured, what state the repair is in, or what is holding it back. Those are three separate checks. The order they are done in decides what the final result can be.
An injury is not a claim to process or a scan to reread. It is a repair project running in a specific biological environment, on a schedule, with a ceiling being set right now.
Frequently Asked Questions
Why does a regenerative practice want my bloodwork before discussing an injection?
Because the injection is autologous, made from your own blood or marrow on the morning of the procedure. The repair it is meant to spark runs on your metabolic budget. Inflammatory load, blood sugar control, vitamin D status, sleep and nicotine exposure shape both the product and the site it goes into. The full argument is in You Cannot Out-Inject a Broken Metabolism.
My injury was not my fault. Why are we talking about my metabolic health?
Fault decides who is responsible for what happened. Terrain decides what can heal now. They are completely separate questions. How whole-body inflammation changes a local repair is set out in Metainflammation: Why the Same Injection Heals One Person and Fails Another.
If the terrain is the problem, is an injection pointless?
No. It is conditional. A catalyst given into a corrected environment does something a catalyst given into an inflamed one cannot. That is why the order is terrain, then target, then treatment, not the reverse. What that evaluation involves is described in What happens during a physician-led Clinical Evaluation.
How is an injury different from ordinary wear and tear?
An injury supplies a date, a cause and a moment when a joint's chemistry changed. It starts a path you can measure decades later. Roughly 12% of hip, knee and ankle osteoarthritis that causes symptoms in the United States follows an injury. That path is the subject of the post-traumatic osteoarthritis clock.
Does this mean you will refuse to treat me if my labs are poor?
It means we will tell you what is limiting your ceiling before you spend anything. Where there is a limiting factor, we treat it first. Deciding that a procedure does not fit today is a normal clinical outcome here, not a rejection, as described in When orthobiologics are not the right treatment.
How can I recover faster from an injury?
Use the first twelve weeks. An injury runs a set arc: inflammation, then rebuilding, then remodeling. What is not fixed during that arc cannot be fixed later at the same cost. Fix what slows repair while the window is open: whole-body inflammation, blood sugar control, vitamins and minerals, sleep, nicotine exposure and the load on the tissue. Your own cells do the repair. The job is to give them the conditions.
How do you heal after a bad fall?
Find out three things, in order: what was actually injured, what state the repair is in, and what is limiting it. An emergency room note that says nothing is broken has answered only one question: nothing needs an operation tonight. If you are no better after weeks of therapy, a physician-led Clinical Evaluation reviews your imaging, history and metabolic data before any procedure is discussed.
Find out what your recovery is actually limited by
Regen.MD begins with a physician-led Clinical Evaluation — a review of your history, your imaging and your metabolic data, and a written terrain roadmap before any procedure is discussed. Evaluation is contingent upon review of your data.
Questions? Call or text us.
Sources
- Brown TD, Johnston RC, Saltzman CL, et al. Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma, 2006. PubMed 17106388 doi:10.1097/01.bot.0000246468.80635.ef
- Leong HT, Fu SC, He X, et al. Risk factors for rotator cuff tendinopathy: a systematic review and meta-analysis. J Rehabil Med, 2019. PubMed 31489438 doi:10.2340/16501977-2598
- Baria M, George R, Barker T, et al. Relationship of body mass index on patient-reported outcomes after platelet-rich plasma versus microfragmented adipose tissue for knee osteoarthritis: a secondary analysis of a randomized controlled trial. Am J Phys Med Rehabil, 2024. PubMed 38630921 doi:10.1097/PHM.0000000000002499
- Manchikanti L, Navani R, Navani A, et al. Comprehensive evidence-based guidelines for regenerative therapies in the management of chronic low back pain: 2025 update from the American Society of Interventional Pain Physicians (ASIPP). Pain Physician, 2025. PubMed 41481869
- Kon E, Di Matteo B, Delgado D, et al. Platelet-rich plasma injections for the management of knee osteoarthritis: the ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surg Sports Traumatol Arthrosc, 2024. PubMed 38961773 doi:10.1002/ksa.12320
- D'Souza RS, Her YF, Hussain N, et al. Evidence-based clinical practice guidelines on regenerative medicine treatment for chronic pain: a consensus report from a multispecialty working group. J Pain Res, 2024. PubMed 39282657 doi:10.2147/JPR.S480559
- Laver L, Filardo G, Sanchez M, et al. The use of injectable orthobiologics for knee osteoarthritis: a European ESSKA-ORBIT consensus. Part 1 — blood-derived products (platelet-rich plasma). Knee Surg Sports Traumatol Arthrosc, 2024. PubMed 38436492 doi:10.1002/ksa.12077
- Bensa A, Sangiorgio A, Deabate L, et al. PRP injections for the treatment of knee osteoarthritis: the improvement is clinically significant and influenced by platelet concentration — a meta-analysis of randomized controlled trials. Am J Sports Med, 2025. PubMed 39751394 doi:10.1177/03635465241246524